Clinical case of thrombotic microangiopathy in obstetric practice: 618.2-005.6

Abstract

Summary. Thrombotic microangiopathy (TMA) is a clinical morphological syndrome developing as a result of microvascular endo- thelium damage caused by various reasons but manifesting similar clinical symptoms and histological signs. Pregnancy is one of the most critical TMA triggers. Pregnancy may be accompanied with secondary TMA development in case of severe preeclampsia and HELLP-syndrome or after massive blood loss complicated with disseminated intravascular coagulation (DIC). The first clin- ical case demonstrates the role of multiple obstetric complications and DIC emerged as a result of failure to timely compensate blood loss in atypical haemolytic-uremic syndrome (aHUS) induction. They may be viewed as additional complement-activating conditions. The described observation illustrates classic progress of secondary aHUS with typical TMA signs. Stopping of fresh frozen plasma (FFP) transfusions and beginning of a target complement blocking therapy (eculizumab) led to significant improve- ment of condition and TMA involution. In the second observation clinical laboratory signs indicated secondary TMA caused by preeclampsia and HELLP-syndrome without acute renal injury. Prescribed basic therapy of preeclampsia, as well as administra- tion of FFP and anticoagulant, allowed to interrupt intravascular hemolysis.

References:

1. Momot A.P., Nikolaeva M.G., Serdyuk G.V. et al. Assessment of hemostasis in physiological pregnancy. Algorithms of examina- tion in high risk groups. Tromboz, gemostaz i reologiya. 2019;(4):80– 130. (In Russ.). DOI: 10.25555/THR.2019.4.0903.

1. Noris M., Mescia F., Remuzzi G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol. 2012;8(11):622–33. DOI: 10.1038/nrneph.2012.195.
2. Kappler S., Ronan-Bentle S., Graham A. Thrombotic microan- giopathies (TTP, HUS, HELLP). Hematol Oncol Clin North Am. 
2017;31(6):1081–103. DOI: 10.1016/j.hoc.2017.08.010. 

3. Throm- botic microangiopathy in obstetrics. Moscow: Ministerstvo zdra- voohraneniya Rossijskoj Federacii, 2017. 11 рp. (In Russ.). Available at: https://xn--d1aaqkhckg.xn--p1ai/files/ZAKON/Fed_clinick_ recomendation/23_tromboticheskaya_mikroangiopatiya_2017.pdf. 

4. Kozlovskaya N.L., Korotchaeva Yu.V., Shifman E.M., Kudlay D.A. Pregnancy-associated atypical hemolytic-uremic syndrome: is pregnancy to blame or its complications? Voprosy ginekolo- gii, akusherstva i perinatologii. 2020;19(4):81–91. (In Russ.). DOI: 10.20953/1726–1678–2020–4–81–91. 

5. Bommer M., Wölfle-Guter M., Bohl S., Kuchenbauer F. The dif- ferential diagnosis and treatment of thrombotic microangio- pathies. Dtsch Arztebl Int. 2018;115(19):327–34. DOI: 10.3238/arz- tebl.2018.0327. 

6. Thrombotic microangiopathies. In: Nephrology. Clinical guide- lines. Eds. E.M. Shilov, A.V. Smirnov, N.L. Kozlovskaya. Moscow: GEOTAR-Media, 2020. 320–88. (In Russ.)
7. Akinshina S.V., Bitsadze V.O., Gadaeva Z.K., Makatsariya A.D. Thrombotic microangiopathy in the pathogenesis of obstetric com- plications. Akusherstvo, Ginekologia i Reprodukcia. 2015;9(2):62–71. (In Russ.). DOI: 10.17749/2070–4968.2015.9.2.062–71.
8. Cines D.B., Levine L.D. Thrombocytopenia in pregnancy. Hema- tology Am Soc Hematol Educ Program. 2017;2017(1):144–51. DOI: 10.1182/asheducation-2017.1.144.
9. Neave L., Scully M. Microangiopathic hemolytic anemia in pregnancy. Transfus Med Rev. 2018;32(4):230–6. DOI: 10.1016/j. tmrv.2018.08.002.
10. Pylaeva N. Yu, Shifman E. M., Kulikov A. V. et al. Preeclamp- sia. Anesthesia and intensive care in childbirth and the puerperium. Review. Vestnik intensivnoj terapii imeni A.I. Saltanova. 2020;(1):41–52. (In Russ.). DOI: 10.21320/1818– 474X-2020–1–41–52.
11. Owens M.Y., Martin J.N., Wallace K. et al. Postpartum thrombotic microangiopathic syndrome. Transfus Apher Sci. 2013;48(1):51–7. DOI: 10.1016/j.transci.2012.05.016.